Anika Therapeutics, Inc. financial data

Symbol
ANIK on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
32 Wiggins Avenue, Bedford, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
ANIKA RESEARCH INC (to 11/27/1996)
Latest financial report
10-K - Q4 2024 - Mar 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 545 % -4.09%
Quick Ratio 159 % +16.3%
Return On Equity -30 % +6.29%
Return On Assets -23.5 % +10%
Operating Margin -4.25 % -708%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.2M shares -4.4%
Common Stock, Shares, Outstanding 14.4M shares -1.66%
Entity Public Float 373M USD +0.73%
Common Stock, Value, Issued 144K USD -2.04%
Weighted Average Number of Shares Outstanding, Basic 14.7M shares +0.44%
Weighted Average Number of Shares Outstanding, Diluted 14.7M shares +0.44%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 120M USD -0.73%
Research and Development Expense 25.5M USD +17.4%
Costs and Expenses 81.1M USD -0.72%
Operating Income (Loss) -5.1M USD -704%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.76M USD -188%
Income Tax Expense (Benefit) 6.06M USD -8.05%
Net Income (Loss) Attributable to Parent -56.4M USD +31.8%
Earnings Per Share, Basic -3.83 USD/shares +32.1%
Earnings Per Share, Diluted -3.83 USD/shares +32.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 55.6M USD -19.1%
Marketable Securities, Current 23.6M USD -10.5%
Accounts Receivable, after Allowance for Credit Loss, Current 23.6M USD -10.5%
Inventory, Net 23.8M USD -2.53%
Assets, Current 114M USD -30.4%
Deferred Income Tax Assets, Net 1.18M USD -21%
Property, Plant and Equipment, Net 39M USD +4.14%
Operating Lease, Right-of-Use Asset 25.7M USD -6.78%
Intangible Assets, Net (Excluding Goodwill) 2.49M USD -3.34%
Goodwill 7.13M USD -5.89%
Other Assets, Noncurrent 5.66M USD -1.21%
Assets 203M USD -25.1%
Accounts Payable, Current 5.62M USD -9.32%
Employee-related Liabilities, Current 6.83M USD -13.9%
Liabilities, Current 23.3M USD -25%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 24M USD -7.34%
Other Liabilities, Noncurrent 772K USD +91.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.78M USD -14.1%
Retained Earnings (Accumulated Deficit) 71.7M USD -44%
Stockholders' Equity Attributable to Parent 154M USD -27.5%
Liabilities and Equity 203M USD -25.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -126K USD +96.5%
Net Cash Provided by (Used in) Financing Activities -2.27M USD -40.9%
Net Cash Provided by (Used in) Investing Activities -1.81M USD -30.2%
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 15M shares +1.09%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.24M USD +35.7%
Deferred Tax Assets, Valuation Allowance 45.1M USD +228%
Deferred Tax Assets, Gross 59.2M USD +97%
Operating Lease, Liability 25.9M USD
Payments to Acquire Property, Plant, and Equipment 1.81M USD +30.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -57.2M USD +30.4%
Property, Plant and Equipment, Gross 85.3M USD +4.72%
Operating Lease, Liability, Current 1.92M USD +4.98%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.47M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.78M USD -11.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 193K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.88M USD -13.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.33M USD -17.9%
Deferred Tax Assets, Operating Loss Carryforwards 650K USD -42.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.25M shares 0%
Unrecognized Tax Benefits 600K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.33M USD -11.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 700K USD +16.7%
Deferred Tax Assets, Net of Valuation Allowance 14.1M USD -13.8%
Share-based Payment Arrangement, Expense 12.2M USD -10.2%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%